Kalpa Pharmaceuticals’ Sildenaxyl contains Sildenafil Citrate in oral tablet form, designed for consistent dosing and reliable formulation. As with all tablet-based products, independent lab testing plays an important role in verifying the actual active substance content per tablet.
Below is the latest available lab test confirming the potency of Sildenaxyl 100 mg, conducted by a trusted third-party laboratory.
Latest Lab Result (2026)
Janoshik Lab Report – 2026-03-24
- Product: Sildenaxyl
- Active Substance: Sildenafil Citrate
- Manufacturer: Kalpa Pharmaceuticals
- Labeled Dosage: 100 mg/tablet
- Result: 92.07 mg/tablet
- Laboratory: Janoshik
This lab test shows a measured content of 92.07 mg per tablet, slightly below the labeled 100 mg dosage. Such variation can occur in tablet manufacturing and remains within a typical range for pharmaceutical formulations.
Potency Analysis
- Labeled dosage: 100 mg
- Measured dosage: 92.07 mg
- Deviation: ~-7.9%
- Laboratory: Janoshik
The measured result indicates a moderate deviation from the labeled dosage. While slightly under label, the result remains within a range commonly observed in tablet-based pharmaceutical products.
About Sildenaxyl (Sildenafil Citrate)
Sildenafil Citrate is a well-known compound used in oral tablet formulations requiring precise dosing. As a tablet-based product, factors such as compression, excipient distribution, and manufacturing processes can influence the final measured content per unit.
Independent lab testing helps provide transparency regarding actual dosage and supports informed evaluation of product consistency.
Conclusion
The available lab test for Kalpa Pharmaceuticals Sildenaxyl 100 mg shows a measured dosage of 92.07 mg per tablet, slightly below the labeled amount. This result reflects a moderate deviation while remaining within a typical range for tablet formulations.
As a newly tested product, additional lab reports over time would provide a clearer picture of batch-to-batch consistency.
Frequently Asked Questions
The available lab result shows 92.07 mg per tablet, slightly below the labeled 100 mg dosage.
Some variation can occur in tablet manufacturing, and small deviations are commonly observed in pharmaceutical testing.
The available report was conducted by Janoshik, an independent laboratory.
Currently, only one lab test is available. Additional reports may provide further insight into consistency across batches.
